Élan

Élan Corporation plc , is a major drugs firm based in Athlone, County Westmeath, Ireland. In the late 1990's its value as a PLC on the ISEQ Stock Exchange reached over €20bn. It was one of Ireland's major business success stories. However in the early years of 2000's an accounting scandal and investor reactions to the globely slump, caused a major devalutation resulting in a share price slump of over 90%. Since then the company has regained its growth path under the reign of a new American CEO Kelly Martin. Today Elán still employs over 2,000 people in Ireland. It is listed on the New York Stock Exchange as ELN, the Dublin Stock Exchange as ELN.I, and the London Stock Exchange as ELN.L.

Elan is currently focusing its research on a ground breaking drug for Alzheimer's disease.

On 28th February 2005, Elán announced that it was withdrawing its Tysabri drug, after reports that a patient died after usage. This has led to its share price dropping by 70%.

See Also

• List of Irish companies

External links

• Elán Homepage
• Information about Elan
• Wikinews report of Tysabr withdrawal
• Élan stock on the Irish Stock Exchange